| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/03/2010 | US7767194 Using cyanine dyes; in situ supplying to tumor cells |
| 08/03/2010 | CA2468295C Glycoprotein remodeling using endoglycanases |
| 08/03/2010 | CA2412183C Rtvp based compositions and methods for the treatment of prostate cancer |
| 08/03/2010 | CA2409432C Modified morbillivirus v proteins |
| 08/03/2010 | CA2381047C Vaccine against hepatitis b virus and human papilloma virus |
| 08/03/2010 | CA2345905C Plant-optimized polynucleotides encoding approximately 15 kda and approximately 45 kda pesticidal proteins |
| 08/03/2010 | CA2283629C Fluorescent protein sensors for detection of analytes |
| 08/03/2010 | CA2263106C Humanized immunoglobulin reactive with .alpha.4.beta.7 integrin |
| 08/03/2010 | CA2247247C Troponin subunits and fragments useful as angiogenesis inhibitors |
| 08/03/2010 | CA2224777C New immunoregulatory protein lst-1 |
| 08/03/2010 | CA2190365C Pigment epithelium-derived factor: characterization, genomic organization and sequence of the pedf gene |
| 08/03/2010 | CA2188813C Angiostatin protein, nucleic acids encoding the same and methods of detection |
| 08/03/2010 | CA2178057C Epstein-barr virus peptides and antibodies against these peptides |
| 08/03/2010 | CA2133873C Tnf inhibitors |
| 07/29/2010 | WO2010085586A1 Secreted phospholipase a2 biomarkers for arthritis |
| 07/29/2010 | WO2010085539A1 Methods and compositions based on shiga toxin type 2 protein |
| 07/29/2010 | WO2010085495A1 Compositions and methods of treating inflammatory and autoimmune diseases |
| 07/29/2010 | WO2010085373A2 Novel bacillus thuringiensis gene with lepidopteran activity |
| 07/29/2010 | WO2010085295A2 Novel bacillus thuringiensis gene with lepidopteran activity |
| 07/29/2010 | WO2010085289A1 Novel bacillus thuringiensis gene with lepidopteran activity |
| 07/29/2010 | WO2010085151A2 Means and methods for modulating notch3 protein expression and/or the coding region of notch3; compositions and use thereof in the treatment of cadasil |
| 07/29/2010 | WO2010085114A2 Abscisic acid carrier gene and transgenic plant expressing same |
| 07/29/2010 | WO2010085100A2 Novel cellular transmembrane domain and intracellular transduction system containing the same |
| 07/29/2010 | WO2010085086A2 Modified human thrombopoietin polypeptide fragment and manufacturing method thereof |
| 07/29/2010 | WO2010085039A2 Noggin-derived peptide and use thereof |
| 07/29/2010 | WO2010085012A1 Method for secreting and producing foreign protein in e. coli |
| 07/29/2010 | WO2010084970A1 Feeder cell for target cell induction |
| 07/29/2010 | WO2010084324A1 Ljungan virus with improved replication characteristics |
| 07/29/2010 | WO2010084173A1 Stable growth hormone compounds |
| 07/29/2010 | WO2010084171A1 Method for temporally controlling the biological activity of proteins in vertebrates, and applications thereof |
| 07/29/2010 | WO2010084136A1 A dominant negative mutants of sam68 for use in the treatment of spinal muscular atrophy (sma) |
| 07/29/2010 | WO2010083615A1 Compositions and methods for silencing apolipoprotein c-iii expression |
| 07/29/2010 | WO2010064208A3 Msp2 antigenic peptides and their use |
| 07/29/2010 | WO2010060934A3 Cnnm proteins and uses thereof |
| 07/29/2010 | WO2010058419A4 Tumor necrosis factor alpha inhibiting peptides and uses thereof |
| 07/29/2010 | WO2010042654A3 Recombinant nell protein production |
| 07/29/2010 | WO2010025530A9 Proteic acid polymer, production processes, use of proteic acid polymer, pharmaceutical composition and method of treatment |
| 07/29/2010 | WO2010020766A3 Interleukin fusion polypeptides |
| 07/29/2010 | WO2009115658A9 Use of a caspase-1 inhibitor for treating atherosclerotic plaque |
| 07/29/2010 | WO2009073808A3 Compositions and methods to modulate cell membrane resealing |
| 07/29/2010 | US20100192257 Late blight resistance genes and methods |
| 07/29/2010 | US20100192256 Novel Bacillus Thuringiensis Gene with Lepidopteran Activity |
| 07/29/2010 | US20100192252 Transcription Factor Gene Induced by Water Deficit Conditions and Abscisic Acid from Helianthus Annuus, Promoter and Transgenic Plants |
| 07/29/2010 | US20100192244 Nucleic acid sequences encoding transcription factors regulating alkaloid biosynthesis and their use in modifying plant metabolism |
| 07/29/2010 | US20100192238 Elongases and methods for producing polyunsaturated fatty acids in transgenic organisms |
| 07/29/2010 | US20100192235 Human chronic lymphocytic leukemia modeled in mouse by targeted tcl1 expression |
| 07/29/2010 | US20100190964 Antibodies to human ErbB4 |
| 07/29/2010 | US20100190962 Novel serpentine transmembrane antigens expressed in human cancers and uses thereof |
| 07/29/2010 | US20100190960 Methods and Compositions for Detection of Ehrlichia chaffeensis (p120) |
| 07/29/2010 | US20100190927 Mhc oligomers, components thereof, and methods of making the same |
| 07/29/2010 | US20100190838 Connective Tissue Growth Factor Fragments and Methods and Uses Thereof |
| 07/29/2010 | US20100190719 Peptides as antimicrobial agents towards campylobacter spp |
| 07/29/2010 | US20100190711 Big gastrin i as a therapeutic agent |
| 07/29/2010 | US20100190710 Il-23 receptor antagonists and uses thereof |
| 07/29/2010 | US20100190708 Composition for amelioration of body lipid |
| 07/29/2010 | US20100190707 Novel Bacillus Thuringiensis Gene with Lepidopteran Activity |
| 07/29/2010 | US20100190703 Peptides specific for human blood outgrowth endothelial cells |
| 07/29/2010 | US20100190702 Compositions and Methods of Treating Neoplasia |
| 07/29/2010 | US20100190701 Glucagon/glp-1 receptor co-agonists |
| 07/29/2010 | US20100190699 GLUCAGON ANALOGS EXHIBITING ENHANCED SOLUBILITY IN PHYSIOLOGICAL pH BUFFERS |
| 07/29/2010 | US20100190698 Neuroprotective peptide inhibitors of AP-1 signaling and uses therefor |
| 07/29/2010 | US20100190697 Undercarboxylated/uncarboxylated osteocalcin increases beta-cell proliferation, insulin secretion, insulin sensitivity, glucose tolerance and decreases fat mass |
| 07/29/2010 | US20100190660 Methods, Compositions And Libraries Pertaining To PNA Dimer And PNA Oligomer Synthesis |
| 07/29/2010 | US20100190655 Fusion polypeptide for detection of conserved combinatorial or composite epitopes in non-conserved proteins |
| 07/29/2010 | US20100190650 Transcriptomic biomarker of myocarditis |
| 07/29/2010 | US20100190238 Synthesis of mycophenolic acid (mpa) |
| 07/29/2010 | US20100190232 Functional Mutations In Respiratory Syncytial Virus |
| 07/29/2010 | US20100190211 IL-18 Receptors |
| 07/29/2010 | US20100190194 Postprandial hyperglycemia marker, method of measuring the same, and usage thereof |
| 07/29/2010 | US20100190192 Method of diagnosing pre-eclampsia |
| 07/29/2010 | US20100190188 Mutant g-protein coupled receptors and methods for selecting them |
| 07/29/2010 | US20100190176 Tumor suppressor designated ts10q23.3 |
| 07/29/2010 | US20100190164 Diagnosis and monitoring of renal failure using peptide biomarkers |
| 07/29/2010 | US20100190161 Mutations in human ubiad1 |
| 07/29/2010 | US20100189776 Anti-androgen peptides and uses thereof in cancer therapy |
| 07/29/2010 | US20100189774 Formation of proteoliposomes containing membrane proteins by means of an acellular protein synthesis system |
| 07/29/2010 | US20100189743 Circovirus sequences associated with piglet weight loss disease (pwd) |
| 07/29/2010 | US20100189742 HPV epitopes targeted by T cells infiltrating cervical malignancies for use in vaccines |
| 07/29/2010 | US20100189740 Modified polysaccharides for conjugate vaccines |
| 07/29/2010 | US20100189739 Immunogenic compositions comprising dal/dat double mutant, auxotrophic attenuated strains of Listeria and their methods of use |
| 07/29/2010 | US20100189738 PORIN B (PorB) AS A THERAPEUTIC TARGET FOR PREVENTION AND TREATMENT OF INFECTION BY CHLAMYDIA |
| 07/29/2010 | US20100189737 Meningococcal vaccines including hemoglobin receptor |
| 07/29/2010 | US20100189736 Circovirus sequences associated with piglet weight loss disease (pwd) |
| 07/29/2010 | US20100189735 Circovirus sequences associated with piglet weight loss disease (pwd) |
| 07/29/2010 | US20100189734 Circovirus sequences associated with piglet weight loss disease (pwd) |
| 07/29/2010 | US20100189733 Circovirus sequences associated with piglet weight loss disease (pwd) |
| 07/29/2010 | US20100189732 Circovirus sequences associated with piglet weight loss disease (pwd) |
| 07/29/2010 | US20100189731 Recombinant avian influenza vaccine and uses thereof |
| 07/29/2010 | US20100189730 Vaccines for human papilloma virus and methods for using the same |
| 07/29/2010 | US20100189727 Masking Ligands For Reversible Inhibition Of Multivalent Compounds |
| 07/29/2010 | US20100189720 Novel card proteins involved in cell death regulation |
| 07/29/2010 | US20100189719 using monoclonal antibody or an Fab fragment capable of binding to mouse Vascular endothelial cell growth factor (VEGF) and human VEGF; cancer, diabetes related diseases, age-induced macular degeneration |
| 07/29/2010 | US20100189718 Molecules with extended half-lives, compositions and uses thereof |
| 07/29/2010 | US20100189689 Tetrameric Cytokines with Improved Biological Activity |
| 07/29/2010 | US20100189686 Albumin Fusion Proteins |
| 07/29/2010 | US20100189682 Biologically active proteins having increased In Vivo and/or In Vitro stability |
| 07/29/2010 | US20100189670 Method for enhancing effects of colorants and conditioners |
| 07/29/2010 | US20100189657 Intramolecularly quenched fluorochrome conjugates and methods of use |
| 07/29/2010 | US20100189649 Monoclonal antibodies to activated erbb family members and methods of use |
| 07/29/2010 | US20100189645 Metal chelators and methods of their use |